- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Shilpa Medicare Limited — Updates, 13-02-2026: General Updates
13-02-2026 | 11:30 am
13-02-2026 | 11:30 am
Shilpa Medicare partnered with NXI Therapeutics (Switzerland) to develop and supply a new drug for autoimmune disorders. SML will handle full manufacturing. This third major international deal boosts SML's CDMO segment, strengthening growth visibility in high-value biologics.
No comments yet. Be the first to comment!